Lariciresinol

• Target :

  TGF-beta/Smad|||glycosidase|||Antifection|||Antifungal|||Apoptosis|||Bcl-2 Family|||NF-?B|||VEGFR

• Related Pathways :

  Tyrosine Kinase/Adaptors|||Metabolism|||Microbiology/Virology|||Apoptosis|||Stem Cells|||Angiogenesis|||NF-?B

• Purity :

  0.9984

• Bioactivity :

  Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

• Smiles :

  C(O)[C@@H]1[C@H](OC[C@@H]1CC2=CC(OC)=C(O)C=C2)C3=CC(OC)=C(O)C=C3

• Molecular Formula :

  C20H24O6

• Molecular Weight :

  360.4

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  27003-73-2